Influence of renal function on the hemodynamic and clinical responses to long-term captopril therapy in severe...

Area of Science:

• Cardiology
• Nephrology
• Pharmacology

Background:

• Severe chronic heart failure presents significant challenges in treatment efficacy.
• Converting-enzyme inhibitors like captopril are crucial in managing heart failure.
• The role of renal function in modulating captopril's effectiveness requires further elucidation.

Purpose of the Study:

• To assess how varying degrees of renal function influence the hemodynamic and clinical outcomes of captopril therapy.
• To identify potential correlations between renal impairment and adverse reactions to captopril.

Main Methods:

• 101 patients with severe chronic heart failure were stratified into three groups based on pretreatment serum creatinine levels.
• Long-term hemodynamic parameters (stroke volume index, filling pressure, systemic vascular resistance) and clinical status were monitored.
• Adverse events, including rash and dysgeusia, were recorded.

Main Results:

• Patients with preserved renal function (Group I) exhibited significantly greater improvements in stroke volume index and reductions in ventricular filling pressure and systemic vascular resistance compared to those with renal impairment (Groups II and III).
• Clinical improvement was markedly higher in patients with preserved renal function (Group I) and mild-to-moderate impairment (Group II) than in those with severe renal insufficiency (Group III).
• Adverse effects like rash and dysgeusia were more prevalent in patients with impaired renal function.

Conclusions:

• Renal function plays a critical role in mediating the beneficial effects of captopril in patients with severe congestive heart failure.
• Reduced renal function is associated with diminished hemodynamic and clinical responses to captopril.
• Therapeutic strategies involving captopril should consider the patient's renal status to optimize outcomes and minimize adverse events.